logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Moderatetosevere Psoriasis Third Edition 3rd Edition John Ym Koo

  • SKU: BELL-1688096
Moderatetosevere Psoriasis Third Edition 3rd Edition John Ym Koo
$ 31.00 $ 45.00 (-31%)

5.0

58 reviews

Moderatetosevere Psoriasis Third Edition 3rd Edition John Ym Koo instant download after payment.

Publisher: CRC Press
File Extension: PDF
File size: 9.75 MB
Pages: 300
Author: John Y.M. Koo, Mark G. Lebwohl, Chai Sue Lee
ISBN: 9781420088670, 9781420088687, 142008867X, 1420088688
Language: English
Year: 2008
Edition: 3

Product desciption

Moderatetosevere Psoriasis Third Edition 3rd Edition John Ym Koo by John Y.m. Koo, Mark G. Lebwohl, Chai Sue Lee 9781420088670, 9781420088687, 142008867X, 1420088688 instant download after payment.

Written by experts in the dermatology field, the new Third Edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and new pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. With 80 high quality color figures and full color throughout, this stand-alone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice.New to the Third Edition:the addition of chapters on the use of infliximab, efalizumab, and Humera, as well as the latest status of clinical trialsthe most up-to-date phototherapy and laser treatment modalitiesstronger coverage of psoriatic arthritis

Related Products